4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuzawa, Y; Hara, T; Ikeda, H; Inoue, Y; Ishikawa, T; Kato, K; Kurokawa, T; Kusunoki, M; Miyata, T; Nakamura, T; Nakaya, Y; Ogawa, H; Okabayashi, N; Otake, K; Sakakibara, F; Tsutsumi, K | 1 |
| Chan, HL; Cheung, KF; Chu, ES; Farrell, GC; Hui, AY; Leung, WK; Sung, JJ; Yu, J | 1 |
2 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and Fatty Liver
| Article | Year |
|---|---|
Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzamides; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diet; Dietary Fats; Enzyme Activators; Fatty Liver; Lipids; Lipoprotein Lipase; Male; Organ Size; Organophosphorus Compounds; Rats; Rats, Wistar | 2004 |
Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
Topics: Animals; Benzamides; Cholesterol; Choline Deficiency; Cyclooxygenase 2; Diet; Enzyme Activation; Fatty Liver; Gene Expression; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Interleukin-6; Lipogenesis; Lipoprotein Lipase; Lipoproteins, HDL; Liver; Male; Methionine; Mice; Mice, Inbred C57BL; Organophosphorus Compounds; PPAR gamma; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2007 |